Details of the Drug Formulaction

General Information of Drug Formulation (ID: F16183)

• Formulation Name: Oxybutynin 15 mg tablet
• Company: NCS HealthCare of KY, Inc dba Vangard Labs

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
Oxybutynine	(DMJPBAX)	Obsolete neurogenic bladder		Investigative

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Beta-D-lactose	(E00099)	6134	Diluent; Dry powder inhaler carrier; Lyophilization aid
Butylated hydroxytoluene	(E00336)	31404	Antioxidant
Magnesium stearate	(E00208)	11177	lubricant
Polysorbate 80	(E00665)	Not Available	Dispersing agent; Emollient; Emulsifying agent; Plasticizing agent; Solubilizing agent; Surfactant; Suspending agent
Sodium chloride	(E00077)	5234	Diluent; Tonicity agent
Titanium dioxide	(E00322)	26042	Coating agent; Colorant; Opacifying agent